Clinical Trials
A Phase II Study Investigating Fruquintinib plus FOLFIRI as Second-Line Treatment for Participants with Metastatic Colorectal Cancer
Disease Type: Colon
A Phase II Study Investigating Fruquintinib plus FOLFIRI as Second-Line Treatment for Participants with Metastatic Colorectal Cancer
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville